TOP特許意匠商標
商標ウォッチ Twitter
公開日2024-12-18
公報種別公開国際商標公報
国際登録番号1816403
国際登録日2024-08-27
区分第5類(薬剤),第42類(科学・技術),第44類(医療・農林業)
商品役務Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; pharmaceutical products and preparations for use in relation to oncology; pharmaceutical products and preparations for use in relation to ophthalmology; pharmaceutical products and preparations for use in relation to neurology; anti-infective pharmaceutical products and preparations; pharmaceutical products and preparations for the treatment and/or prevention of respiratory disease; pharmaceutical products and preparations for the treatment and/or prevention of cardiovascular disease; pharmaceutical products and preparations for the treatment and/or prevention of metabolic disease; pharmaceutical products and preparations for the treatment and/or prevention of viral infections; pharmaceutical products and preparations for use in diagnostics and imaging; pharmaceutical products and preparations for the treatment and/or prevention of renal disease; pharmaceutical products and preparations for the treatment and/or prevention of gastrointestinal disease; pharmaceutical products and preparations for the treatment and/or prevention of muscular skeletal disease.,Scientific and technological services and research and design relating thereto; industrial analysis and research services; pharmaceutical research and development services; medical research and development services; pharmaceutical testing and clinical trials; medical testing and clinical trials; research and development in the field of oncology; research and development in the field of ophthalmology; research and development in the field of neurology; research and development in the field of anti-infective pharmaceuticals; research and development in the field of respiratory disease; research and development in the field of cardiovascular disease; research and development in the field of metabolic disease; research and development in the field of antiviral drugs; research and development in the field of diagnostics and imaging; research and development in the field of renal disease; research and development in the field of gastrointestinal disease; research and development in the field of muscular skeletal disease; information consultancy and advisory services relating to the aforesaid.,Medical services; healthcare services; pharmaceutical services; medical consulting services; advisory services relating to pharmaceuticals; consultancy and information services relating to pharmaceuticals; medical services in the field of oncology; medical services in the field of ophthalmology; medical services in the field of neurology; medical services in the field of anti-infectives; medical services in connection with respiratory disease; medical services in connection with cardiovascular disease; medical services in connection with metabolic disease; medical services in connection with the treatment and/or prevention of viral infections; medical services in connection with diagnostics and imaging; medical services in connection with renal disease; medical services in connection with gastrointestinal disease; medical services in connection with muscular skeletal disease; pharmaceutical services in the field of oncology; pharmaceutical services in the field of ophthalmology; pharmaceutical services in the field of neurology; pharmaceutical services in the field of anti-infectives; pharmaceutical services in connection with respiratory disease; pharmaceutical services in connection with cardiovascular disease; pharmaceutical services in connection with metabolic disease; pharmaceutical services in connection with the treatment and/or prevention of viral infections; pharmaceutical services in connection with diagnostics and imaging; pharmaceutical services in connection with renal disease; pharmaceutical services in connection with gastrointestinal disease; pharmaceutical services in connection with muscular skeletal disease; information, consultancy and advisory services relating to the aforesaid.
基礎出願番号UK00004024691
基礎出願日2024-03-12
基礎出願国GB
出願人Bicycletx Limited
OCRテキスト
OCRテキスト2B
OCRについて
この商標をJ-PlatPatで参照する
Flag Counter

関連商標

DRUGS MINERALS AND GENERICS ITALIA S.R.L. in forma abbreviata D.M.G. ITALIA S.R.L.
STOMATOVIS
8か月前
COSWELL S.p.A.
BLANX
5か月前
個人
SPEEDEX
8日前
BOLERO & Co Ltd.
BOLERO
1か月前
Triticum Exploitatie B.V.
L-MESITRAN
2か月前
個人
PARABOND
8か月前
個人
GI-MASK
4か月前
Ferring B.V.
FERPRONT
10か月前
Novartis AG
VRESKEZ
11か月前
Novartis AG
SAMAALB
11か月前
Novartis AG
OJUVIP
2か月前
BOYAN IVANOV ANASTASOV
SUPER SPORT
6か月前
ALTUNKAYA INSAAT NAKLIYAT GIDA TICARET ANONIM SIRKETI
CONFY
7か月前
INTERSALES COMPANY, naamloze vennootschap
FORNATURAL ENERGY MALT DRINK AND VITALITY
4か月前
Neurocrine Biosciences, Inc.
wwv
10か月前
Alcon Inc.
TRYPTYR
3か月前
Lantheus Medical Imaging, Inc.
ZURELIDY
1か月前
Premier Foods Group Limited
FUEL10K
4か月前
UCB Biopharma SRL
RAPZETY
6か月前
Professional Dietetics S.p.A.
SUNEKOS
4か月前
Vetsense Pty Ltd
VETSENSE
4か月前
OLIVIT Sp. z o.o.
osavi
1か月前
個人
RAGWIZAX
11か月前
AFT PHARMACEUTICALS LIMITED
Kiwisoothe
4か月前
NOVARTIS AG
STIMESQUE
4か月前
YUHAN CORPORATION
YUHAN
8か月前
Applied Nutrition Limited
APPLIED NUTRITION
5か月前
JEITO CAPITAL
ito
10か月前
NOVARTIS AG
INTYMGO
4か月前
NOVARTIS AG
REGNYTIM
4か月前
NOVARTIS AG
DYNTIMIC
4か月前
TLC - Tender Loving Care UK Ltd
CHEWYVITES
2か月前
NOVARTIS AG
ATIMUET
4か月前
NOVARTIS AG
IMTYTIM
4か月前
Novartis AG
RHAPSIDO
7か月前
Alcon Inc.
TRIPTYR
3か月前
続きを見る